Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
From Critical Care Explorations
The authors piloted a randomized trial of IV immunoglobulin in coronavirus disease 2019 patients and found significantly improved hypoxia and reduced hospital length of stay.
Authors:
Sakoulas G, Geriak M, Kullar R, et al.
Estimated Time: 23:01
Categories:
Research, Crisis Management,
Content Type:
Articles,